Detalles de la búsqueda
1.
Major hurdles to the use of tyrosine kinase inhibitors in clinical prevention/interception studies: Do preclinical studies with EGFR inhibitors suggest approaches to overcome some of the limitations.
Front Cell Dev Biol
; 11: 1170444, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37169023
Resultados
1 -
1
de 1
1
Próxima >
>>